Abstract:Objective To evaluate and compare the antibody to hepatitis B virus (HBV) surface antigen (anti-HBs) response and the influent factors of revaccination of 4 kinds of hepatitis B vaccine (HepB) among firstly low-response adults.Methods A total of 11 590 adults who were 18-49 years old,never received HepB vaccination,without HBV infection history,HBs-Ag negative,and had been living at 3 towns of Zhangqiu county in Shandong province Ji'nan city for more than half a year,were selected in the study in July,2009.Self-designed questionnaire was used to select the basic information of the subjects.The subjects were divided into 4 groups by cluster sampling,and were vaccinated according to the "0-1-6"immune procedure with 10 μgHepB made by recombinant deoxyribonucleic acid techniques in Saccharomyces Cerevisiae (HepB-SC),10 μg HepB made by recombinant deoxyribonucleic acid techniques in Hansenula Polymorpha (HepB-HP),20 μg HepB-SC and 20 μg HepB made by recombinant dexyribonucleic acid techniques in Chinese hamster ovary cell (HepB-CHO),3 doses respectively.The adults who were low-response to the primary hepatitis B vaccination (10 mU/ml≤anti-HBs ＜ 100 mU/ml)were divided into four groups by cluster sampling.These groups were revaccinated with one-dose of above-mentioned four kinds of HepB respectively.Blood samples were drawn from each person one month after the revaccination.Anti-HBs was detected by chemiluminescence microparticle immunoassay and compared by the vaccine type.The influence factors about antibody response were also analyzed.Results Out of the 11 590 subjects,8592 adults had accepted the primary vaccination of hepatitis B and been collected the blood samples; among whom,1306 subjects showed low-response,at the rate of 15.20％A total of 1034 low-response subjects accepted secondary strengthened vaccination and were collected blood samples; 55.13％ of them showed anti-HBs seroconversion (anti-HBs ≥ 100 mU/ml ); while the seroeonversion rate in each group was 44.54％ (106/238) in 10 μg HepB-SC group,57.14％ (156/273)in 10 μg HepB-HP group,56.08％ (143/255) in 20 μg HepB-SC group and 61.57％ (165/268) in 20 μg HepB-CHO group,respectively.There was significant difference among the groups (X2=17.14,P ＜ 0.01 ).The rates of anti-HBs seroconversion were significantly higher in 10 μg HepB-HP and 20 μg HepB-CHO groups than it in 10 μg HepB-SC group ( X2 were 8.09 and 14.70 respectively,P ＜ 0.01 ).The geometric mean concentration (GMC) of anti-HBs was 178.24 mU/ml among the low-responders after one dose of revaccination.The GMC was 109.77,243.50,144.98 and 242.83 mU/ml in 10 μg HepB-SC group,10 μg HepB-HP group,20 μg HepB-SC group and 20 μg HepB-CHO group,respectively.There was significant difference among groups ( F =9.52,P ＜ 0.01 ).Conclusion Anti-HBs response could be strengthened effectively after one-dose of HepB revaccination among the low-response adults.Many factors like the vaccine typs could effect the immune effects to HepB.A better response could be achieved if the 20 μg HepB-CHO or 10 μg HepB-HP was used for revaccination.

Assessment on Serological Survey of Antibody to Hepatitis B Virus Surface Antigen Response to Revaccination of 5μg Recombinant Hepatitis B Vaccine Derived from Yeast with Different Type, Different Dosage and Different Schedule among Low-response Infants

Monitoring the Efficacy of Infant Hepatitis B Vaccination and Revaccination in 0- to 8-Year-old Children: Protective Anti-Hbs Levels and Cellular Immune Responses.

Study on antibody response to revaccination of hepatitis B vaccine among firstly low-response adults

Revaccination of Non- and Low- Responders after a Standard Three Dose Hepatitis B Vaccine Schedule

Antibody Response and the Influencing Factors after Revaccination with Three Doses of Hepatitis B Vaccines among Low-Response Adults

[Comparison on the Antibody Response after Primary Immunization of 5 Μg and 10 Μg Hepatitis B Vaccine Made by Recombinant DNA Techniques among Newborns].

[A Five-Year Observation on Efficacy of Revaccination in Children of Non-Response to Hepatitis B Vaccine].

[Effect analysis on non-and-low response infants after revaccinated hepatitis B vaccine]

[Anti-HBs persistence after revaccination with three doses of hepatitis B vaccine among low-responder infants following primary vaccination: 4-year of follow-up]

Effect of Revaccination Using Different Schemes among Adults with Low or Undetectable Anti-HBs Titers after Hepatitis B Virus Vaccination

Antibody Response To Revaccination Among Adult Non-Responders To Primary Hepatitis B Vaccination In China

The One Year Effects of Three Doses of Hepatitis B Vaccine As a Booster in Anti-Hbs-negative Children 11–15 Years after Primary Immunization; China, 2009–2011

Study on Effect and Duration of Hepatitis B Vaccine Made by Deoxyribonucleic Acid Techniques with Saccharomyces Cerevisiae Yeast after Long-term Vaccination

[Serum Antibody Response to Different Doses of Hepatitis B Vaccine Made by Recombinant DNA Techniques in Yeast and Hansenula Polymorpha Yeast].

Hepatitis B Revaccination in Healthy Non-Responder Chinese Children: Five-Year Follow-Up of Immune Response and Immunologic Memory.

Effects of hepatitis B vaccine boosters on anti-HBs-negative children after primary immunization.

Strategies for Hepatitis B Booster Vaccination among Children: an 8-Year Prospective Cohort Study

[Immune Effects of Three Different Programs for Revaccination among Adults of Non- and Hypo-Responders to Hepatitis B Vaccine].

An observation on the long-term efficacy of recombinant hepatitis B vaccines among the newborns

[Matching Study on Immune Response Between Single Anti-Hbc Positivity and Healthy Adults after Primary Immunization and Revaccination of Hepatitis B Vaccine].

The effects of booster vaccination of hepatitis B vaccine on children 5-15 years after primary immunization: a 5-year follow-up study.